tirzepatide vial 2.5mg Zepbound Injection 2.5 mg/0.5 mL — Mountainside Medical Lilly launches lower-price weight-loss drug
Description
Microdosing requires even more precise syringe technique because the volumes involved are very small, making syringe selection and careful drawing technique even more critical

Hartman ML, Sanyal AJ, Loomba R, Wilson JM, Nikooienejad A, Bray R, Karanikas CA, Duffin KL, Robins DA, Haupt A

Arrived well packaged with foam cushioning and ice pack

Small air bubbles injected subcutaneously are harmless

& Carey, V

Adults receiving tirzepatide lost a mean 4.7 kg of body weight from 36 to 88 weeks compared with an 11.1 kg weight gain for the placebo group
